Postmarketing safety surveillance of dexamethasone intravitreal implant in the treatment of visual impairment due to diabetic macular edema in India

BACKGROUND: Diabetic macular edema (DME) is the most common cause of vision loss in diabetic patients. As India has the second largest population of diabetic patients worldwide, availability of various treatment options for DME is essential. This postmarketing surveillance study was conducted to ful...

Descripción completa

Detalles Bibliográficos
Autores principales: Nair, Unnikrishnan, Gupta, Vishali, Sharma, Mohita, Joshi, Shrinivas, Sudhalkar, Aditya, Altangerel, Undraa, Bai, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545916/
https://www.ncbi.nlm.nih.gov/pubmed/33036583
http://dx.doi.org/10.1186/s12886-020-01630-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545916/
https://www.ncbi.nlm.nih.gov/pubmed/33036583
http://dx.doi.org/10.1186/s12886-020-01630-7

Ejemplares similares